December 2023 - Zahrawi

Zahrawi Group Histopathology & Cytology team proudly joined forces with our esteemed partner BD at the Emirates Surgical Pathology Conference held from December 15 to 17, 2023, at the Address Marina Hotel in Dubai, UAE.

This year’s edition was held under the theme “Pushing Boundaries through Innovation,” the conference served as a crucial platform, uniting pathologists, scientists, and diagnostics industry representatives. It facilitated the exchange of insights, recent research findings, and the introduction of cutting-edge technologies.

Our team seized this occasion to showcase groundbreaking solutions from our partners, such as the BD Viper, a state-of-the-art molecular system that enables fully automated and integrated molecular testing. The Pi Slide Printer and Pi Cassette Printer from CellPath, present innovative advancements in specimen processing and labelling.

One of the conference’s pivotal moments was the informative talk hosted by BD on their Cervical Cancer Screening Solutions. This session presented the latest advancements in cervical cancer screening, aligning seamlessly with our mission to provide cutting-edge healthcare solutions that positively impact patient outcomes.

Congratulations to our team for such a successful event!

Zahrawi Group is proud to announce that our Nuclear Medicine Team successfully supplied the first case of Lutetium Therapy in Oman using products from our partner ITM. This significant milestone not only reinforces our commitment to advancing healthcare solutions but also places us at the forefront of nuclear medicine therapy in the region.

Lutetium, a rare and invaluable therapeutic nuclide, holds immense promise in the treatment of cancer patients. Zahrawi Group is honored to be the first to introduce this cutting-edge therapy to Oman, in collaboration with the esteemed Sultan Qaboos Comprehensive Cancer Care and Research Center (SQCCCRC), a State-of-the-Art Healthcare facility.

Our dedicated team, with invaluable support from local regulatory authorities, worked tirelessly for the completion of this project and to ensure a successful introduction of Lutetium Therapy, which will bring a significant transformation in the medical landscape of Oman, presenting novel and effective treatment alternatives for cancer patients.

Zahrawi Group remains steadfast in its mission to bring cutting-edge healthcare solutions to the region, and we would like to thank our partners #ITM & #LEVALIS for making this achievement possible.